Latest news
Pfizer (PFE) Reports Positive Phase 3 LITFULO Data In Vitiligo - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:13:26 GMTPfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance - businesswire.combusinesswire.com · Tue, 04 Aug 2026 10:45:00 GMTPhase III Trials Show Positive Results for Ritlecitinib in Nonsegmental Vitiligo - Medical DialoguesMedical Dialogues · Sun, 02 Aug 2026 23:30:18 GMTPfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings - Indian Pharma PostIndian Pharma Post · Sat, 01 Aug 2026 14:24:34 GMTPfizer’s Litfulo meets Phase III goals in vitiligo, supporting regulatory filings - The Pharma LetterThe Pharma Letter · Fri, 31 Jul 2026 07:00:00 GMTPfizer (PFE) Pushes Litfulo Toward Regulators In Vitiligo Battle Against Incyte And AbbVie - londoninsider.co.uklondoninsider.co.uk · Thu, 30 Jul 2026 21:05:40 GMTPfizer's ritlecitinib advances to become first oral systemic therapy for nonsegmental vitiligo - AllSciAllSci · Thu, 30 Jul 2026 16:35:55 GMTPfizer seeks label expansion for Litfulo after double Phase III NSV win - Clinical Trials ArenaClinical Trials Arena · Thu, 30 Jul 2026 15:45:49 GMT